Inotersen

Tegsedi

284 MG / 1.5 ML SolutionCanadaCancelledAuthorised 7 Jan 2019

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Tegsedi 284 MG Solucion Inyectable en Jeringa PrecargadaSpain · 200 mg/ml · solución inyectable en jeringa precargada · Akcea Therapeutics Ireland LimitedSame brand
TegsediEuropean Union · Akcea Therapeutics Ireland LimitedSame brand
TegsediCroatiaSame brand
TegsediItaly · Soluzione iniettabile · Akcea Therapeutics Ireland LimitedSame brand
Tegsedi 189 mg/ml, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Akcea Therapeutics Ireland LtdSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Inotersen

Tegsedi

284 MG / 1.5 ML SolutionCanadaCancelledAuthorised 7 Jan 2019

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

TegsediUnited States · 284MG BASE/1.5ML · solution · Akcea Theraps

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Inotersen
Strength: 284 MG / 1.5 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 7 Jan 2019
Registration: DIN 02481383
Marketing authorisation holder: Akcea Therapeutics, INC.
ATC code: N07XX15
Group: Nervous system
Supply: PRESCRIPTION